David Gibbons helps clients achieve their growth and capital raising goals. With more than 25 years of experience in mergers and acquisitions and other business combinations, David offers pragmatic advice to multinational companies, private equity funds, investment banks, and growth stage enterprises on highly complex deals. He focuses his practice on cross-border and multijurisdictional transactions.

Clients rely on David to handle complex joint ventures, strategic alliances, private equity investments, exits, securities, and complex licensing arrangements. He represents a diverse array of clients, from the world's largest aerospace and defense company, to private equity funds, and start-up ventures. David advises issuers, underwriters, boards, and shareholders on securities issuances, reporting and disclosure issues, and general corporate governance matters.

David provides practical, results-driven advice. David is immersed in his clients' industries, and is a member of the global industry groups at Hogan Lovells, including Aerospace & Defense; Life Sciences and Health Care; Automotive and Mobility; Diversified Industrials; Private Capital; and Technology, Media, and Telecoms. He leads the global Corporate & Finance practice group at Hogan Lovells and serves on the firm's international management committee.

Active in numerous pro bono and community activities, David serves on the boards of the Baltimore Area Council, Boys Scouts of America, and CollegeBound. He is a graduate of the Greater Baltimore Committee's LEADERship Program.

Awards and recognitions


Corporate/M&A, Notable practitioner, Global-wide
Chambers Global


Mergers, Acquisitions, and Buyouts: M&A: Large Deals ($1bn-5bn)
Legal 500 US

Education and admissions


J.D., Emory University School of Law, 1991

B.A., University of Virginia, 1988


Executive Committee Member, Baltimore Area Council of the Boy Scouts of America

Member, American Bar Association

The Leadership, Baltimore

Bar admissions and qualifications


District of Columbia

Representative experience

Represent Helsinn Group on its strategic collaboration with BridgeBio Pharma affiliate, QED Therapeutics, Inc., to co-develop and commercialize Infigratinib in oncology.


Represent Lockheed Martin Corporation on acquisitions, divestitures, securities offerings, joint ventures, and other corporate matters, including its pending US$4.4bn acquisition of Aerojet Rocketdyne.

Represented Accenture in connection with numerous transactions including acquisitions of The Zenta Group, ASM Research, Inc., and Maxim Systems, Inc.

Represented Helsinn Healthcare SA in the acquisition of Sapphire Pharmaceuticals.

Represented ABS Capital Partners in the acquisitions of Alarm.com from Microstrategy Incorporated and ConnectYourCare LLC from Express Scripts.

Represented PPG Industries in the US$2.3bn acquisition of Consorcio Comex, S.A. de C.V.

ABS Capital Partners in investments in Ignite Media Solutions, InVision Holdings, Florida Tower Partners, Syncapse, Vibrant Media, and Zoom Media.

Represented ABS Capital in the US$136m investment by Technology Crossover Ventures in Alarm.com.

Represented Helsinn Healthcare SA in connection with the acquisition of the worldwide rights to Valchlor© / Legada© from Actelion Pharmaceutical, Ltd.

Loading data